Cargando…
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
Red blood cell transfusions remain one of the cornerstones in supportive care of lower-risk patients with myelodysplastic syndromes. We hypothesized that patients develop oxidant-mediated tissue injury through the formation of toxic iron species, caused either by red blood cell transfusions or by in...
Autores principales: | de Swart, Louise, Reiniers, Chloé, Bagguley, Timothy, van Marrewijk, Corine, Bowen, David, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Cermak, Jaroslav, van de Loosdrecht, Arjan A., Garelius, Hege, Culligan, Dominic, Macheta, Mac, Spanoudakis, Michail, Panagiotidis, Panagiotis, Krejci, Marta, Blijlevens, Nicole, Langemeijer, Saskia, Droste, Jackie, Swinkels, Dorine W., Smith, Alex, de Witte, Theo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777192/ https://www.ncbi.nlm.nih.gov/pubmed/29122992 http://dx.doi.org/10.3324/haematol.2017.171884 |
Ejemplares similares
-
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
por: Hoeks, Marlijn, et al.
Publicado: (2020) -
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
por: Stauder, Reinhard, et al.
Publicado: (2018) -
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
por: Hoeks, Marlijn, et al.
Publicado: (2020) -
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
por: de Witte, Theo, et al.
Publicado: (2020) -
P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
por: Savic, Aleksandar, et al.
Publicado: (2023)